NCT00186849View on ClinicalTrials.gov

Therapy for Children With Advanced Stage High Risk Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions
Neuroblastoma
Interventions
DRUG

Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, Carboplatin

See Detailed Description section for details of treatment interventions.

PROCEDURE

Peripheral Blood Stem Cell Transplant

See Detailed Description section for details of treatment interventions.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00186849 - Therapy for Children With Advanced Stage High Risk Neuroblastoma | Biotech Hunter | Biotech Hunter